Common use of Final Research and Development Reports Clause in Contracts

Final Research and Development Reports. The Parties will exchange final reports of their results within six (6) months after the expiration or termination of this CRADA. These reports will set forth the technical progress made; any publications arising from the research; and the existence of invention disclosures of potential CRADA Subject Inventions and/or any corresponding Patent Applications.

Appears in 30 contracts

Samples: Public Health Service, And Development Agreement, Research and Development Agreement (Ziopharm Oncology Inc)

AutoNDA by SimpleDocs

Final Research and Development Reports. The Parties will exchange final reports of their results within six four (64) months after the expiration or termination of this CRADA. These reports will set forth the technical progress made; any publications arising from the research; and the existence of invention disclosures of potential CRADA Subject Inventions and/or any corresponding Patent Applications.

Appears in 12 contracts

Samples: Public Health Service (BriaCell Therapeutics Corp.), Cooperative Research and Development Agreement (Scopus BioPharma Inc.), Development Agreement (Scopus BioPharma Inc.)

Final Research and Development Reports. The Parties will exchange final reports of their results within six (6) months after the expiration or termination of this CRADA. These reports will set forth the technical progress made; any publications arising from the research; and the existence of invention disclosures of potential CRADA Subject Inventions and/or any corresponding Patent Applications. Abstracts and publications provided to CTEP by investigators and further provided by CTEP to Collaborator will fulfill this final report obligation.

Appears in 5 contracts

Samples: Material Transfer Agreement (Newlink Genetics Corp), Research and Development Agreement (Newlink Genetics Corp), Research and Development Agreement (Newlink Genetics Corp)

Final Research and Development Reports. The Parties will exchange final reports of their results within six (6) months […***…] after the expiration or termination of this CRADA. These reports will set forth the technical progress made; any publications arising from the research; and the existence of invention disclosures of potential CRADA Subject Inventions and/or any corresponding Patent Applications.

Appears in 2 contracts

Samples: Research and Development Agreement (Kite Pharma, Inc.), Research and Development Agreement (Kite Pharma, Inc.)

Final Research and Development Reports. The Parties will exchange final reports of their results within six forty-five (645) months days after the expiration or termination of this CRADA. These reports will set forth the technical progress made; any publications arising from the research; and the existence of invention disclosures of potential CRADA Subject Inventions and/or any corresponding Patent Applications.

Appears in 1 contract

Samples: Development Agreement (Virpax Pharmaceuticals, Inc.)

AutoNDA by SimpleDocs

Final Research and Development Reports. The Parties will exchange final reports of their results within six (6) months [*] after the expiration or termination of this CRADA. These reports will set forth the technical progress made; any publications arising from the research; and the existence of invention disclosures of potential CRADA Subject Inventions and/or any corresponding Patent Applications.

Appears in 1 contract

Samples: Public Health Service (Introgen Therapeutics Inc)

Final Research and Development Reports. The Parties will exchange final reports of their results within six (6) months after the expiration or termination of this CRADA. These reports will set forth the technical progress made; any publications arising from the research; and the existence of invention disclosures of potential CRADA Subject Inventions and/or any corresponding Patent Applications.. PHS ICT-CRADA Agreement Ref. No. 03434 MODEL ADOPTED June 18, 2009

Appears in 1 contract

Samples: Cooperative Research and Development Agreement (Curative Biotechnology Inc)

Final Research and Development Reports. The Parties will exchange final reports of their results within six four (64) months after the expiration or termination by mutual consent of this CRADACRADA or four (4) months after Leidos Biomedical ends work on the Joint Work Statement in case of unilateral termination by Collaborator. These reports will set forth the technical progress made; , any publications arising from the research; , and the existence of invention disclosures of potential CRADA Subject Inventions and/or any corresponding Patent Applications.

Appears in 1 contract

Samples: Leidos Biomedical

Time is Money Join Law Insider Premium to draft better contracts faster.